Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 1/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.46 |
| ▸ | AR | P10275 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3389444 | 0.91 | CA1 (0.58) | ACP3CA4LTA4HALDH1A1CA12 | |
| SCHEMBL17599983 | 0.87 | ACP3 (0.56) | ACP3CA4LTA4HALDH1A1PBRM1 | |
| SCHEMBL11784757 | 0.83 | ACP3 (0.58) | ACP3CA4LTA4HALDH1A1PBRM1 | |
| SCHEMBL3131759 | 0.83 | CA4 (0.54) | ACP3CA4LTA4HALDH1A1PBRM1 | |
| SCHEMBL9765970 | 0.83 | ACHE (0.65) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL13295540 | 0.82 | SLC2A1 (0.61) | ACP3CA4LTA4HALDH1A1PBRM1 | |
| SCHEMBL14205685 | 0.82 | SLC2A1 (0.61) | ACP3CA4LTA4HALDH1A1PBRM1 | |
| SCHEMBL13295537 | 0.82 | SLC2A1 (0.61) | ACP3CA4LTA4HALDH1A1PBRM1 | |
| SCHEMBL40557 | 0.82 | SLC2A1 (0.61) | ACP3CA4LTA4HALDH1A1PBRM1 | |
| SCHEMBL8429413 | 0.82 | PBRM1 (0.62) | ACP3CA4LTA4HALDH1A1PBRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-58072499-A | — | — | None | — | — | JP | disclosed |
| US-12006311-B2 | Compounds for use in preventing or treating cancer | FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRONINSTITUT DE RECERCA (ES) | 2024-06-11 | — | — | US | disclosed |
| WO-2024083861-A1 | 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF | SELABTEC SCIENCES, SLU (ES) | 2024-04-25 | — | — | WO | disclosed |
| EP-4356909-A1 | 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF | Selabtec Sciences, SLU (ES) | 2024-04-24 | — | — | EP | disclosed |
| EP-3645548-B1 | METHODS FOR PREPARING BILE ACIDS | MEDYTOX INC (KR) | 2023-11-29 | — | — | EP | disclosed |
| CN-111328332-B | Process for the preparation of bile acids | 玫帝托克斯股份有限公司 | 2023-01-24 | — | — | CN | disclosed |
| EP-3271468-B1 | DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES | LABORATORIO TECNICO DE SEGURIDAD Y ESTANDARIZACION SL (ES) | 2022-12-14 | — | — | EP | disclosed |
| CN-107849594-B | Deamination of organophosphorus nucleosides | 科技学专业学院有限公司 | 2022-01-18 | — | — | CN | disclosed |
| US-20220009957-A1 | Methods for Preparing Bile Acids | MEDYTOX INC. (KR) | 2022-01-13 | — | — | US | disclosed |
| US-11161872-B2 | Methods for preparing bile acids | MEDYTOX INC. (KR) | 2021-11-02 | — | — | US | disclosed |
| US-20050014715-A1 | Inosine compounds and their use for treating or preventing an inflammation or reperfusion disease | SALZMAN ANDREW L (US) | 2005-01-20 | — | — | US | disclosed |
| EP-1487829-A1 | THIADIAZOLYLPIPERAZINE DERIVATIVES USEFUL FOR TREATING OR PREVENTING PAIN | Euro-Celtique S.A. (LU) | 2004-12-22 | — | — | EP | disclosed |
| US-20040235853-A1 | Therapeutic agents useful for treating pain | PURDUE PHARMA L.P. | 2004-11-25 | — | — | US | disclosed |
| US-20040044003-A1 | Therapeutic agents useful for treating pain | PURDUE PHARMA L.P. | 2004-03-04 | — | — | US | disclosed |
| EP-1383505-A2 | INOSINE COMPOUNDS AND THEIR USE FOR TREATING OR PREVENTING AN INFLAMATION OR A REPERFUSION DISEASE | Inotek Pharmaceuticals Corporation (US) | 2004-01-28 | — | — | EP | disclosed |
| US-20040006091-A1 | Therapeutic agents useful for treating or preventing pain | PURDUE PHARMA L.P. | 2004-01-08 | — | — | US | disclosed |
| WO-2003074520-A1 | THIADIAZOLYLPIPERAZINE DERIVATIVES USEFUL FOR TREATING OR PREVENTING PAIN | EURO-CELTIQUE, S.A. (LU) | 2003-09-12 | — | — | WO | disclosed |
| US-20030040502-A1 | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | INOTEK PHARMACEUTICALS CORPORATION | 2003-02-27 | — | — | US | disclosed |
| WO-2002076400-A2 | INOSINE COMPOUNDS AND THEIR USE FOR TREATING OR PREVENTING AN INFLAMATION OR A REPERFUSION DISEASE | INOTEK PHARMACEUTICALS CORPORATION (US) | 2002-10-03 | — | — | WO | disclosed |
| JP-S5872499-A | HEAT-SENSITIVE RECORDING MATERIAL | FUJI PHOTO FILM CO LTD | 1983-04-30 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040006091-A1 | Therapeutic agents useful for treating or preventing pain | OPRK1, OPRL1, OPRD1 | ACP3 989/4885CA4 2524/4885LTA4H 326/4885 |
| US-20030040502-A1 | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | NOS2, NOS1, ARG2 | ACP3 3201/4885CA4 3389/4885LTA4H 922/4885 |
| US-20220009957-A1 | Methods for Preparing Bile Acids | DHCR7, CYP46A1, CYP27A1 | ACP3 134/4885CA4 1030/4885LTA4H 2045/4885 |
| US-20050014715-A1 | Inosine compounds and their use for treating or preventing an inflammation or reperfusion disease | NOS2, NOS1, NOS3 | ACP3 2541/4885CA4 3872/4885LTA4H 1087/4885 |
| US-11161872-B2 | Methods for preparing bile acids | DHCR7, CYP46A1, CYP27A1 | ACP3 134/4885CA4 1030/4885LTA4H 2045/4885 |
| US-12006311-B2 | Compounds for use in preventing or treating cancer | UGT1A3, UGT1A1, UGT1A6 | ACP3 91/4885CA4 303/4885LTA4H 1436/4885 |
| US-20040235853-A1 | Therapeutic agents useful for treating pain | OPRM1, OPRL1, ALPI | ACP3 2539/4885CA4 3709/4885LTA4H 220/4885 |
| US-20040044003-A1 | Therapeutic agents useful for treating pain | GRIK5, HBS1L, GABRR1 | ACP3 4562/4885CA4 4713/4885LTA4H 1755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.